<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>enzyment10q.txt
<TEXT>
                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25
                           NOTIFICATION OF LATE FILING

Commission File Number: 333-162170
                        ----------
(Check One):  [ ] Form 10-K                   [X] Form 10-Q
              [ ] Form 20-F  [ ] Form 11-K    [ ] Form N-SAR

For Period Ended: September 30, 2009
                  ------------------
[ ] Transition Report on Form 10-K    [ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K    [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

For the Transition Period Ended:

If the notification  relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

                               Enzyme Bio Systems
                            -------------------------
                             Full Name of Registrant

                                       N/A
                            -------------------------
                            Former Name if Applicable

                                16773 W. Park Dr.
            ---------------------------------------------------------
            Address of Principal Executive Office (Street and Number)

                             Chagrin Falls, OH 44023
                            -------------------------
                            City, State and Zip Code

PART II - RULES 12b-25(b) and (c)

If the subject report could not be filed without  unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)

[X]  (a) The reasons described in reasonable detail in Part III of this form
         could not be eliminated without unreasonable effort or expense;

[X]  (b) The subject annual report, semi-annual report, transition report on
         Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,  will
         be filed on or before the fifteenth  calendar day following the
         prescribed due date; or the subject quarterly report or transition
         report on Form 10-Q, or portion thereof will be filed on or before
         the fifth calendar day following the prescribed due date; and

[ ]  (c) The accountant's  statement or other exhibit required by Rule 12b-
         25(c) has been attached if applicable.

<PAGE>

PART III - NARRATIVE

State below in reasonable  detail the reasons why the Form 10-K, 11-K, 20-F,
10-Q,  N-SAR, or other transition  report or portion thereof, could not be
filed within the prescribed period.

     The Registrant was unable to complete its audit and preparation of its
10-Q in a timely matter because of unanticipated delays.

PART IV - OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to
this notification

           Ashot Martirosyan             (440)             708-0012
           -------------------------------------------------------------
           (Name)                     (Area Code)     (Telephone Number)

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports), been filed? If answer is
no, identify report(s).                                       [X] YES [ ] NO

(3)  Is it anticipated that any significant change in results of operations
from the corresponding  period for the last fiscal year will be reflected by
the earnings statement to be included in the subject report or portion thereof?
                                                              [ ] YES [X] NO

If so, attach an explanation of the anticipated change,  both narratively,
and, if  appropriate,  state the  reasons  why a  reasonable  estimate of the
results cannot be made.

                                Enzyme Bio Systems
                  --------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its  behalf by the undersigned
hereunto duly authorized.


Date: November 16, 2009            By: /s/ Ashot Martirosyan
                                       -------------------------------------
                                           Ashot Martirosyan
                                    Title: Principal Executive Officer

<PAGE>

</TEXT>
</DOCUMENT>